Both the products have been developed for India and other global geographies.

Other healthcare innovations including Allura Centron, and PrimaryDiagnost, have also been innovated in India and are manufactured at HIC's Pune facility.

As part of its global strategy, HIC will function as a healthcare innovation and manufacturing hub for India and international markets.

Designed and developed by a team of 25 engineers at HIC, MobileDiagnost Opta is an innovative digital X-ray system that helps radiologists with consistent diagnostic image quality with mobility and ease of use in restricted places like Intensive Care Units (ICU) and Operation Theatres (OT).

"We have our manufacturing, R&D and commercial headquarters in India. We have the highest focus on healthcare, and it gets sharper and sharper. It is about addressing challenges that countries and patients face. For us innovation starts with patients. That's the heart of everything we do. We do local manufacturing, simultaneously focusing on global markets reaching multiple geographies," said Ms Rekha Ranganathan, global general manager, mobile surgery & head, Philips Healthcare Innovation Center.

The mobile surgery system BV Vectra mobile C-arm system is intuitive to operate and is dedicated to orthopedic surgical procedures, including trauma, spine and pain management.

The system, developed by a team of 45 engineers is perfect for visualizing difficult spinal or comminuted fractures.

Philips' healthcare segment occupies 40 percent, followed by its lighting business at 34 percent and consumer lifestyle at 26 percent.

HIC is Philips' only such center in emerging markets, said the company in a press statement.

The center was inaugurated in 2012. In the last 2-3 years, the center has filed 4 patents, and 36 disclosures.

We are not just manufacturing in India, but we do our R&D and manufacture products for India as well as global markets in more than 90 countries. This is a real testament to 'Make in India' campaign," commented Mr Sameer Garde, president, Philips Healthcare, South Asia.

In 2014, Philips invested approximately 8 percent of sales in R&D globally.